Cancer
Cancer, June 14 promises to be a day filled with emotional awareness, nurturing relationships, and taking small steps towards personal dreams. Your intuitive insights guide your choices, and communication flows smoothly, allowing you to express feelings. With a focus on tasks and compassion towards others, you may experience rewards and
Cancer
Researchers at the University of Michigan have made a significant advancement in cancer immunotherapy by designing a potent oral stimulator of interferon genes (STING) agonist, ZSA-215, which achieves complete tumor regression and long-term survival in mice. This breakthrough has the potential to revolutionize the treatment of various types of cancer,
Cancer
Survivors of cancer can expect to experience more significant declines in physical wellbeing compared to those without a cancer diagnosis. According to a study published in BMC Medicine, researchers from the Australian National University found that even after treatment, cancer survivors can expect to experience greater physical and psychological declines
Cancer
Research published online in Cancer Discovery suggests that circulating tumor DNA can be detected more than three years prior to a clinical cancer diagnosis, potentially providing a window for earlier management and treatment. Researchers from the Johns Hopkins School of Medicine in Baltimore, led by Nickolas Papadopoulos, Ph.D., analyzed
Cancer
A new study published in the Journal of Photonics presents a comprehensive review of the latest advancements in guided mode resonant (GMR) sensors for early cancer screening. Researchers from the University of York, led by Pankaj K. Sahoo, have explored the potential of GMR-based sensors in detecting cancer biomarkers, highlighting
Cancer
A team of researchers from Guizhou University has designed and synthesized a novel nanoplatform that combines photodynamic therapy (PDT) with photothermal therapy (PTT) to overcome cancer treatment resistance in hypoxic tumors. The study, published in the journal Lasers in Medical Science, demonstrates the efficacy of the PEGylated liposomes in enhancing
Cancer
Vivian Campbell, guitarist of the band Def Leppard, was diagnosed with Hodgkin's lymphoma in 2013 and has been battling the disease for over a decade. After undergoing various treatments, including immunotherapy, Campbell finally achieved remission after a successful bone marrow transplant in 2022. In an interview with SiriusXM&
Cancer
New research from the Victor Babes University of Medicine and Pharmacy in Timisoara, Romania, has highlighted the potential of Sodium-glucose cotransporter-2 (SGLT2) inhibitors in reducing cardiac toxicity associated with cancer treatment. According to the study, SGLT2 inhibitors have shown pleiotropic cardioprotective effects, including reduced oxidative stress, inflammation, and myocardial remodeling,
Cancer
People experiencing homelessness are significantly more vulnerable to developing cancer and face dismal health outcomes compared to their housed counterparts. Research from University Hospital North Tees reveals that this population encounters multiple health disparities, including delayed cancer treatment and reduced access to palliative care. The lack of trust between healthcare
Cancer
The US Food and Drug Administration (FDA) has granted accelerated approval to afamitresgene autoleucel, a melanoma-associated antigen-A4 (MAGE-A4)-directed genetically modified autologous T-cell immunotherapy, for the treatment of adults with unresectable or metastatic synovial sarcoma (SS) who have received prior chemotherapy. This approval represents a major breakthrough in the treatment
Cancer
Researchers at the University of Washington conducted a prospective cohort study to assess whether paired normal-tumour testing increased access to targeted therapy, clinical trials, and influenced cancer screening recommendations for patients with gastric cancer. The study found that 76.2% of the 42 patients included in the study were eligible
Cancer
Research at Jinzhou Medical University has provided new insights into the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in cancer therapy. According to a recent study, SHP2 modulators have shown promise as a tumor therapeutic target due to their ability to regulate tumor cell growth and proliferation, as well
